Stockreport

2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results

2seventy bio, Inc.  (TSVT) 
PDF $242 million in U.S. Abecma sales in 2024Approximately $184 million of cash, cash equivalents and marketable securities as of December 31, 2024Net cash burn of $9 millio [Read more]